Actually Wegovy is good for dialysis companies, dialysis provider says
Why GLP-1 treatments like Wegovy could actually help dialysis companies, despite initially destabilizing dialysis provider stocks:
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning, everyone. Damian here with a look at the legacy of a pharma CEO, yet more biotech layoffs, and a reprieve from the GLP-1 panic.
What's Your Reaction?
